A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes

计划入组 19 人 · 首次发布于 2021 年 7 月 9 日

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

计划入组 40 人 · 首次发布于 2024 年 7 月 19 日

Ketones, SGLT2, HFrEF

计划入组 71 人 · 首次发布于 2024 年 1 月 29 日

SGLT1/SGLT2/DPP4 Inhibitor(Tonghua Dongbao Pharmaceutical Co., Ltd.)

SGLT1 inhibitors (Sunshine Lake)

SGLT1 inhibitors(China Medical University)

FDA Advisory Committee Rejects Zynquista for Type 1 Diabetes and Chronic Kidney Disease

FDA Advisory Committee Rejects Zynquista for Type 1 Diabetes and Chronic Kidney Disease

Sotagliflozin Improves Glycemic Control in Type 2 Diabetes Patients on Insulin Therapy